Oppenheimer Maintains Outperform on Corteva, Raises Price Target to $89

Benzinga Newsdesk www.benzinga.com Positive 89.1%

Neg 0% Neu 0% Pos 89.1%

Oppenheimer analyst Kristen Owen maintains Corteva (NYSE:CTVA) with a Outperform and raises the price target from $86 to $89.